Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients

Clinical trial NCT06500741 · COMPLETED

Trial details

NCT number: NCT06500741
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Prostate Cancer

Start date: 2024-11-22
Primary completion: 2025-04-02
Enrollment: 374

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.